Mpox Hepatic and Pulmonary Lesions in HIV/Hepatitis B Virus Co-Infected Patient, France

Emerg Infect Dis. 2024 Nov;30(11):2445-2447. doi: 10.3201/eid3011.241331.

Abstract

We report a case of persistent disseminated mpox evolving over >6 months in an HIV/hepatitis B virus co-infected patient in France who had <200 CD4+ cells/mm3, pulmonary and hepatic necrotic lesions, persistent viremia, and nasopharyngeal excretion. Clinical outcome was favorable after 90 days of tecovirimat treatment and administration of human vaccinia immunoglobulins.

Keywords: France; HBV; HIV; HIV/AIDS and other retroviruses; VIGIV; hepatitis B virus; human vaccinia immune globulins; liver; liver abscess; lungs; monkeypox virus; mpox; necrotic lesions; sexually transmitted infections; tecovirimat; vaccinia immune globulins intravenous; viruses; zoonoses.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • Coinfection* / diagnosis
  • Coinfection* / drug therapy
  • Coinfection* / virology
  • France
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Hepatitis B virus
  • Hepatitis B* / complications
  • Hepatitis B* / drug therapy
  • Hepatitis B* / virology
  • Humans
  • Lung / diagnostic imaging
  • Lung / pathology
  • Lung / virology
  • Mpox (monkeypox)* / complications
  • Mpox (monkeypox)* / drug therapy
  • Mpox (monkeypox)* / virology

Substances

  • Antiviral Agents